Impact

Our Impact

This movement is driven by an exceptional community of patients, survivors, doctors, researchers, caregivers, and supporters. Together they have raised more than $180 million for rare cancer research in just ten years. 100 percent of the donations have advanced more than 100 clinical trials, studies, and major research initiatives. Every dollar represents hope, strength, and a lasting impact. 

Cycle for Survival Funds Progress

The work supported by Cycle for Survival has led to important discoveries. Many doctors and  scientists on the front lines in the battle against rare cancers couldn’t have pursued innovative ideas without Cycle for Survival funding. Learn about some of the incredible progress made: Read the featured research updates on this page. And check back throughout the year for new information on Cycle for Survival-funded breakthroughs.

Our Impact

"Children with brain cancers urgently need better and safer treatment options and more effective ways to deliver the therapy. Cycle for Survival funding has been critical in advancing the research and clinical trials that will help pediatric patients.”

Ira J. Dunkel, MD
Department of Pediatrics

"Funding from Cycle for Survival enables me and my colleagues to pursue exciting new ways to treat ovarian cancer, and to prevent the disease from recurring. Thank you to the Cycle for Survival community for supporting vital research."

Roisin E. O'Cearbhaill, MD
Gynecologic Medical Oncology Service

News and Publications

Popular Mechanics Thumb

What Miraculous Recoveries Can Teach Us About Beating Cancer

When only a couple of people out of a hundred respond to a cancer drug, that drug is often shelved as a failure. But what if you're one of those two people?

Our Impact - News 2

Molecular Studies Provide New Clues about Rare Soft Tissue Sarcoma

A recent Memorial Sloan Kettering study suggests new ways to control malignant peripheral nerve sheath tumors (MPNSTs), a rare, aggressive type of soft tissue sarcoma.

Time Thumb

Closing the Cancer Gap

No two cancers are alike; even within an individual patient, tumors may change over time. And doctors are learning that a melanoma growth might have more in common with a lung cancer or a brain cancer than another melanoma.

Download more information

2016 Funding Allocation

Download PDF  >

2015 Funding Allocation

Download PDF  >

2014 Funding Allocation

Download PDF  >

2013 Funding Allocation

Download PDF  >

Stay
Informed